Question 1

What are the expected benefits of trying LY317615 compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. clinical trial (NCT00042666). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I be aware of while taking this medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. clinical trial (NCT00042666). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. clinical trial (NCT00042666). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. clinical trial (NCT00042666). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any additional tests or procedures involved in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. clinical trial (NCT00042666). Contact the study team or your healthcare provider for specific answers.

Question 6

How will participating in this trial affect my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. clinical trial (NCT00042666). Contact the study team or your healthcare provider for specific answers.

What this study is about